The National Antimicrobial Resistance Monitoring System (NARMS) has published its 2019 Integrated Report Summary, which reviews antimicrobial resistance trends in Salmonella, Campylobacter, generic E. coli, and Enterococcus. The report also discusses genomic information for Salmonella, Campylobacter and E. coli in retail meat and food producing animals.
NARMS is a partnership between FDA, CDC, USDA’s FSIS, the Animal and Plant Health Inspection Service, the Agricultural Research Service, and other state and local public health departments and federal agencies. The national surveillance in the report helps all public health partners identify new types and patterns of resistance and changes over time.
“FSIS and the CDC use NARMS information on a case-by-case basis to investigate foodborne illnesses and outbreaks. FDA routinely uses NARMS data in its regulatory review and approval of new animal antimicrobial drugs, and to develop and update policies on the judicious use of antimicrobial in animals. NARMS findings help public health partners continually assess the nature and magnitude of bacterial antibiotic resistance at different points along the farm-to-fork continuum.” – USDA
The report includes a new way to calculate multidrug resistance (MDR), which means a resistance to three or more antimicrobial drug classes. The method is supposed to provide more consistency to the NARMS year-to-year MDR trend analysis and comparisons.
The Integrated Report Summary is available on FDA’s website.